- $167.80bn
- $219.60bn
- $62.58bn
Vaxcyte shares surge as pneumococcal vaccine meets main trial goals
Vaxcyte surges on pneumococcal vaccine late-stage trial success
Brief: Pfizer Says Litfulo Safety Profile In NSV Consistent With Alopecia Areata
Factbox: Major drugmakers turn to China for licensing deals
US RESEARCH ROUNDUP-Arxis, Cigna, Vylor
Trump Medicare drug pricing model may apply to only four companies after exemptions
Florida Attorney General sues Pfizer and CEO over COVID-19 vaccine claims (updated)
Florida Attorney General sues Pfizer and CEO over COVID-19 vaccine claims
Brief: Florida Attorney General Files Lawsuit Against Pfizer And Its CEO Albert Bourla
Brief: Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Celcuity gains as breast cancer drug launches in US
Factbox: Major drugmakers turn to China for licensing deals
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Pfizer, Moderna lose bids to escape Bayer US mRNA patent lawsuit (updated)
Pfizer, Moderna lose bids to escape Bayer US mRNA patent lawsuit
Factbox: US drugmakers turn to China for licensing deals
Corrected: BioNTech to shutter three sites in Germany as no buyers emerge
China's Xi to visit Washington without CEO delegation, sources say